Ameritas Advisory Services’s Microbot Medical MBOT Stock Holding History

Ameritas Advisory Services’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,186	Closed	-$3.62K	–	1641
2025 Q3	$3.62K	Hold	1,186	–	–	﹤0.01%	1900
2025 Q2	$2.99K	Buy	+1,186	New	+$2.84K	﹤0.01%	2394
2023 Q2	–	Sell	-1,473	Closed	-$3.06K	–	1729
2023 Q1	$3.06K	Buy	+1,473	New	+$4.36K	﹤0.01%	2292

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Advisory Services's MBOT Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Microbot Medical (MBOT) in Q4 2025, closing a stake of 1,186 shares — an estimated $3.62K sold.

Ameritas Advisory Services first reported a position in MBOT in Q1 2023 and held it in 3 quarters. The position peaked at $3.62K in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.

Ameritas Advisory Services reported no remaining Microbot Medical position as of Q4 2025 after selling out during the quarter.
Ameritas Advisory Services sold 1,186 Microbot Medical shares in Q4 2025, an estimated $3.62K.
Ameritas Advisory Services first reported a position in Microbot Medical in Q1 2023 and held it in 3 quarters.
Ameritas Advisory Services's Microbot Medical position peaked at $3.62K in Q3 2025.
70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.